Press release
Cystinuria Treatment Market Growth Trends, Regional Breakdown, Segmentation, Restraints, and Forecast to 2024-2031 | Travere Therapeutics, Inc., Dr. Reddy's Laboratories Ltd., Advicenne.
Cystinuria Treatment Market || 2024-2031
Get a Free Sample PDF - https://datamintelligence.com/download-sample/cystinuria-treatment-market
What is the projected growth rate (CAGR) of the Global Cystinuria Treatment market from 2024 to 2031, and what is the market value expected to change by 2031?
The Global Cystinuria Treatment Market reached USD 110.7 million in 2023 and is expected to reach USD 153.8 million by 2031 growing with a CAGR of 4.3% during the forecast period 2024-2031.
What is Cystinuria Treatment Market?
The Cystinuria Treatment market addresses therapies for cystinuria, a genetic disorder that leads to recurrent kidney stones due to cystine buildup in the urine. This market includes medications, dietary supplements, and minimally invasive surgical procedures to manage symptoms and prevent stone formation. Growth drivers include increased awareness, ongoing research for targeted therapies, and the demand for effective, preventive treatments to improve patient outcomes.
Who are the major players in the Cystinuria Treatment market?
The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world. The prominent players in Cystinuria Treatment market research report are: Travere Therapeutics, Inc., Dr. Reddy's Laboratories Ltd., Advicenne, Teva Pharmaceutical Industries Ltd., ANI Pharmaceuticals, Inc., Viatris Inc., AdvaCare Pharma, Camber Pharmaceuticals, Inc., Bausch Health Companies Inc., and Panacea Biotec among others.
Key Development
On November 28, 2022, Lupin Limited announced that its Brazilian subsidiary, MedQumica Indstria Farmacêutica, had entered into a binding agreement to acquire the rights to nine drugs from BL Indstria tica Ltda., a division of Bausch Health Companies Inc.
On May 17, 2021, Teva Pharmaceuticals, a subsidiary of Teva Pharmaceutical Industries Ltd., launched the first generic version of THIOLA (tiopronin) tablets in the United States. This medication is prescribed alongside increased fluid intake, alkalizing agents, or dietary changes to help prevent cystine kidney stones in adults and pediatric patients over nine years old with severe homozygous cystinuria who have not responded to these treatments alone.
Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=cystinuria-treatment-market
Regions Covered:
The global Cystinuria Treatment Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
Market Segments
By Type: Cystinuria Type 1, Cystinuria Type 2, Cystinuria Type 3.
By Drugs: Tiopronin (Thiola), Penicillamine, Captopril, Others.
By Route of Administration: Oral, Injectables.
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.
The Cystinuria Treatment industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.
Key Features
➥ Leverage epidemiology insights to tailor precision diagnostics and address region-specific needs.
➥ Meet critical unmet needs in complex conditions with advanced, precise Cystinuria Treatment industry solutions for better diagnostics and outcomes.
➥ Stay ahead with real-time pipeline analysis, revealing the latest Cystinuria Treatment innovations and market trends.
➥ Optimize your offerings with competitive pricing analysis, balancing cost-effectiveness and cutting-edge tech.
➥ Protect your innovation with expert patent analysis, ensuring strategic positioning in the Cystinuria Treatment market.
➥ Gain an edge with comprehensive competitive intelligence, guiding informed decisions in Cystinuria Treatment
➥ Maximize market presence with brand share analysis, strengthening your position in the Cystinuria Treatment landscape.
➥ Accurately predict market demand for Cystinuria Treatment with precise drug sales forecasting insights.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/cystinuria-treatment-market
FAQs
What does the Cystinuria Treatment market report provide?
The report provides a detailed analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Active, Innovators, Start-ups, and Cutting Edge) that are anticipated to influence its future growth trajectory.
What is the scope of the market report?
The market report covers regional analysis and provides detailed insights into the Cystinuria Treatment market including market size, segmentation, and key players.
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cystinuria Treatment Market Growth Trends, Regional Breakdown, Segmentation, Restraints, and Forecast to 2024-2031 | Travere Therapeutics, Inc., Dr. Reddy's Laboratories Ltd., Advicenne. here
News-ID: 3713246 • Views: …
More Releases from DataM Intelligence 4Market Research
United States Peripheral Neuropathy Market Set for Transformative Growth with Ri …
Market Size and Growth:
The Peripheral Neuropathy Market size was valued US$ 1,539 million in 2021 and is estimated to reach US$ YY million by 2031, growing at a CAGR of 4.2% during the forecast period (2024-2031).
The Peripheral Neuropathy Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants…
United States Acute Coronary Syndrome Market Set for Robust Growth with Advancem …
Market Size and Growth:
The Global Acute Coronary Syndrome Market size reached US$ 9.94 billion in 2023 and is expected to reach US$ 14.70 billion by 2031, growing at a CAGR of 5.1% during the forecast period 2024-2031.
The Acute Coronary Syndrome Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for…
United States Atrial Fibrillation Market Surges with Breakthrough Therapies and …
Market Size and Growth:
The Global Atrial Fibrillation Market size reached US$ 26.75 billion in 2024 and is expected to reach US$ 63.79 billion by 2033, growing at a CAGR of 10.6 % during the forecast period 2025-2033.
The Atrial Fibrillation Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market…
United States Personalized Cancer Vaccines Market Set for Breakthrough Growth wi …
Market Size and Growth:
The Global Personalized Cancer Vaccines Market size reached US$ 11.33 Billion in 2024 from US$ 10.21 Billion in 2023 and is expected to reach US$ 30.12 Billion by 2033, growing at a CAGR of 11.5% during the forecast period 2025-2033.
The Personalized Cancer Vaccines Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in…
More Releases for Cystinuria
Cystinuria Market to Reach USD 2.5 Billion by 2034
Cystinuria is a rare inherited metabolic disorder characterized by defective renal transport of certain amino acids, particularly cystine, which leads to the formation of recurrent kidney stones. This autosomal recessive condition is caused by mutations in the SLC3A1 and SLC7A9 genes and affects approximately 1 in 7,000 to 1 in 10,000 individuals worldwide.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71685
Although not life-threatening when managed effectively, cystinuria poses a…
Future Scope of Cystinuria Treatment Market Expects to See Significant Growth Du …
"
The Cystinuria Treatment Market addresses a rare inherited metabolic disorder characterized by the excessive excretion of cystine, an amino acid, in the urine. This condition leads to the formation of cystine stones in the kidneys, ureters, and bladder, causing significant pain, urinary tract infections, and potentially kidney damage. The market encompasses various treatment options aimed at managing the condition, including medications to dissolve or prevent stone formation, surgical procedures to…
Cystinuria Pipeline 2025: Groundbreaking Clinical Advancements by 5+ Global Lead …
With Cystinuria reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing demand for safer, more effective treatment options. According to DelveInsight, the Cystinuria pipeline comprises 5+ pharmaceutical and biotech companies actively developing 5+ therapeutic candidates targeting Cystinuria. These therapies span various stages of clinical and non-clinical development, underscoring the intense innovation and commitment to addressing one of…
Cystinuria Market Report: Epidemiology, Trends and Forecast to (2023-2033)
IMARC Group has recently released a report titled "Cystinuria Market: Analysis of Epidemiology, Industry Trends, Size, Share, and Future Forecast (2023-2033)" that presents a comprehensive assessment of the cystinuria market. The report provides an extensive overview of the latest market trends, growth prospects, investment opportunities, and industry outlook, as well as an in-depth analysis of the disease landscape, market size, and growth trends. Furthermore, the report offers an analysis of…
Cystinuria Treatment Market is expected to grow at a CAGR of 6.00% during the fo …
Data Bridge Market Research analyzes that the Cystinuria Treatment Market will grow at a CAGR of roughly 6.00% during the forecast period 2021-2028. Growing demand for targeted therapies, increased research and development activities for the development of new drugs and therapies, and increased expenditures for the development of healthcare infrastructure are the major factors attributable to growth of the cystinuria treatment market.
Cystinuria is a rare inherited condition that causes…
Cystinuria Market: Industry Analysis, Treatment, Pipeline Drugs and Key Companie …
Cystinuria is an inherited metabolic disorder characterized by the abnormal movement (transport) in the intestines and kidneys, of certain organic chemical compounds (amino acids). These include cystine, lysine, arginine, and ornithine. Excessive amounts of undissolved cysteine in the urine (cystinuria) cause the formation of stones (calculi) in the kidney, bladder, or ureter.
DelveInsight's 'Cystinuria Market Insight, Epidemiology and Market Forecast - 2032' report deliver an in-depth understanding of the disease, historical…
